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Abstract: It is a fact that the use of antibiotics is inducing a growing resistance on bacteria. 
This situation is not only the consequence of a drugs’ misuse, but a direct consequence of 
a widespread and continuous use. Current studies suggest that this effect could be reversed 
by using abandoned antibiotics to which bacteria have lost their resistance, but this is only 
a temporary solution that in near future would lead to new resistance problems. Fortunately, 
current nanotechnology offers a new life for old and new antibiotics, which could have 
significantly different pharmacokinetics when properly delivered; enabling new routes able 
to bypass acquired resistances. In this contribution, we will focus on the use of porous silica 
nanoparticles as functional carriers for the delivery of antibiotics and biocides in combination 
with additional features like membrane sensitizing and heavy metal-driven metabolic- 
disrupting therapies as two of the most interesting combination therapies. 
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Introduction
The discovery of penicillin enabled modern societies to cope with a large number of 
diseases caused by bacteria; diseases that until then, lacked an effective treatment 
and caused a large number of victims. Since that moment and upon democratization 
of antibiotics, infections could be controlled. However, this effect pushes bacteria to 
evolve and be more and more resistant against antibiotics, pushing too the research-
ers to find and develop more sophisticated compounds able to keep infections at 
bay.1,2 Nevertheless and unfortunately, the current situation suggests that acquired 
resistance grows faster than the development of new-generation antibiotics.3,4 
However, the arrival of nanotechnology has permitted us to design new strategies 
to deliver these old antibiotics to bacteria in a different manner,5–7 just like that 
which happened in other branches of nanomedicine, such as cancer.
Among all the available nanotechnologies suitable to treat infections,6,8,9 we 
will focus herein on the use of porous silica-based technologies. They are one of the 
few materials that can easily combine in single entities an efficient drug-delivery 
profile,10–14 as reported by our group two decades ago,15,16 together with a facile 
(bio)chemical modification. These two complementary aspects permit us to create 
fancy multicomponent nanodevices able to exert combination therapy17,18 onto 
cells; as already covered by us in several bibliographic revisions on cancer17–19 
and infection.7,8,12 In addition to this synthetic modularity it is also important to 
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remark on the advances made on increasing batchreprodu-
cibility and scale-up, which will allow us to overcome 
laboratory-scale bottlenecks and address semi-industrial 
synthesis20 and thus face the commercialization of anti-
biotic nanodevices.
Regarding the chemical species to be delivered by 
mesoporous silica carriers it is possible to find typical 
antibiotics, but also peptides and proteins21 or plant 
extracts; although most of the examples deal with the 
delivery of small-sized molecules. At this point, we will 
address a comprehensive study of the different strategies 
followed to incorporate such antibiotics into silica nano-
carriers; although again, most of reported strategies deal 
with the use of typical antibiotics. Apart from this sys-
tematic study on the combination of antibiotics and meso-
porous silica nanoparticles (MSNs), we will also address 
the combination of MSNS with other biocidal species such 
as metals and poly-ionic species that show promising 
antibacterial effects and could be easily combined with 
the in-pore loading and delivery of drugs.
The intrinsic advantages of MSNs over other types of 
nanomaterials go beyond their porous structure capable of 
loading drugs of a different nature. For instance, among 
inorganic particles MSN have a superior loading capacity 
over solid nanoparticles such as iron oxide, gold and silver 
nanostructures and carbon-based systems such as nano-
tubes and graphene.22 Regarding biocompatibility, MSNs 
have a superior performance over nondegradable gold and 
carbon-based structures.23 This is a direct consequence of 
a water-driven dissolution24 that permits an effective 
clearance from tissues. This effect, extensively reviewed 
by us and other research groups during the last years,25–27 
is not as quick as the clearance showed by iron oxides, but 
enough to prevent chronic toxicities. When compared with 
organic nanosystems such as liposomes, polymeric nano-
particles and dendrimers, MSNs have a superior structural 
and chemical stability and ease of functionalization, which 
permits them to develop synthetic modifications upon 
loading. But one of the most important features of silica 
is its enormous versatility of prepared hybrid systems 
which would be hardly prepared with other materials. 
Among its inconveniences, it should be remarked the 
stiffness of the resulting particles that unless properly 
prepared may lead to undesired accumulations in alveoli 
and blood capillaries that may produce embolisms. 
Regarding antibiotic effects, the topic of the current 
review, silica has no relevant effects on the bacteria, 
being silver colloids with a superior antibiotic efficacy 
either as therapeutics or adjuvants.28 In summary, we 
have chosen to review MSNs on antibacterial nanosystems 
because their drug delivery properties, stability, and com-
bination versatility will provide them a brilliant future 
in the development of new generation antibiotics.
Delivery of Antibiotic Compounds
Drug Delivery Employing 
Surface-modified Silica Particles
The modification of particles with antibiotics was one of 
the first nanotechnological strategies to face bacterial 
infection, as it could be implemented in most nanoparticles 
Figure 1 Strategies to prepare antibiotic-loaded nanoparticles. The possibility of drug release feature would be enabled or not depending on the methodology employed.
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with ease (Figure 1). Along this line, and focusing on 
silica-based nanosystems, Qi et al pioneered the use of 
these nanoparticle-antibiotic conjugates to treat infections. 
In their work the authors coupled the vancomycin glyco-
peptide onto MSNs to obtain a highly biocompatible 
hybrid nanodevice. This system was able to achieve selec-
tive recognition and antibiotic effect over pathogenic 
gram-positive bacteria infecting macrophage-like cells.29 
In this case, the recognition between the MSNs⊂Van and 
the gram-positive bacterial walls occurred due to a highly 
specific interaction between the glycopeptide and the term-
inal D-Ala-D-Ala moieties present on walls. In contrast, 
the interaction of MSNs⊂Van with gram-negative bacteria 
was attributed to nonspecific electrostatic interactions 
between MSNs⊂Van and the negatively charged bacterial 
walls. As a result, the nanosystem achieved a minimum 
inhibitory concentration (MIC) for Staphylococcus aureus 
around 200 μg/mL, while viabilities on eukaryotic cells 
were above 90% with up to 1 mg/mL concentrations. In 
vivo assays on mice proved a drop in bacterial colony- 
forming units (CFUs) 10-fold, which permitted us to aug-
ment survival of infected mice. In a similar approach by 
Agnihotriet al, there were reported the use of aminoglyco-
side-conjugated MSNs to treat resistant bacteria.30 On 
their example a convenient epoxide modification onto the 
MSNs’ surfaces permitted us to graft antibiotic aminogly-
cosides (gentamicin, neomycin, and kanamycin) through-
out their amino functions. The resulting systems had a nice 
colloidal stability due to the positively charged outermost 
layer but without significant hemolysis rates, which may 
permit their intravenous administration. Indeed, in all 
tested bacteria the hybrid had a significant bacteriostatic 
effect, maintaining OD below 0.2, which indicates the 
absence of forming biofilms. (Table 1)
Another interesting possibility to develop antibacterial 
nanoparticles was tackled by Dong et al who explored the 
possibilities of N-halamine compounds (former hypochlor-
ite releasers) as antibacterial agents. On their first contri-
bution, the authors prepared a copolymer of MMA and 
allyl-barbituric acid onto SiO2 NPs which were then oxi-
dized with NaClO to provide the corresponding 
halamine.31 In a more recent example the allyl-barbituric 
acid was replaced by a tetramethylpiperidine (TMP) that 
upon oxidation with NaClO provided the desired 
N-halamine-loaded particles.32 As a result both systems 
were able to promote bacterial death on gram-positive 
and gram-negative bacteria (P. aeruginosa, S. aureus, 
and Escherichiacoli) due to a sustained chlorine release. 
In a comparison between both models, the best antibacter-
ial effect corresponds to the TMP-containing copolymer, 
which permitted us to obtain thicker coatings and hence 
higher chlorine deliveries. Nevertheless, the toxic effect of 
intracellular delivery of highly reactive chlorine species, 
may limit the application of these kind of nanodevices into 
living systems, as they would probably destroy eukaryotic 
cells and bacteria alike. Nevertheless, it is a promising 
strategy for the destruction of bacteria in nonliving sys-
tems. (Table 1)
Pore Loading and Delivery of Antibiotic 
Drugs
Another valuable strategy for antibiotic delivery in 
employing their three-dimensional structure to host and 
release drugs. This approach was first reported by 
Capeletti et al, who prepared tetracycline-loaded SiO2 
NPs in situ from TEOS and a solution of tetracycline 
and ammonia.33 The in vitro evaluation showed that 
encapsulation improved the killing effect on E. coli, 
although as well as nonloaded SiO2 NPs, which suggests 
a particle-assisted antibacterial effect. However, as the 
system was not tested on eukaryotic cells, it may be 
possible that this strategy of surface unmodified particles 
may not be suitable for in vivo application.
Apart from typical delivery, several groups have also 
focused their research on how the morphology, textural 
properties and functionalization affect the drug load and 
delivery processes and how this affects the overall anti-
bacterial effect. In an example by Nor et al the authors 
studied the effect of different roughness of silica nanopar-
ticles in the release of vancomycin.34 In this work different 
sets of nanoparticles were prepared with different poros-
ities and roughnesses, which provided significant differ-
ences between them on their hydrophobic properties. The 
systems employed were smooth hollow MSNs (H-MSNs), 
rough solid SiO2 NPs (R-SiO2NPs), and rough hollow 
MSNs (RH-MSNs). The authors discovered that RH- 
MSNs performed better because these particles showed 
higher loading capacities as a consequence of the internal 
void, together with a more sustained release due to the 
more hydrophobic surface roughness. However, the asso-
ciated antibacterial effect of vancomycin-loaded H-MSNs 
and RH-MSNs did not differ significantly against E. coli 
formed colonies, as the OD (600 nm) obtained showed 
similar values. However, the time-dependent antibacterial 
study proved that RH-MSNs were able to fully destroy 
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bacteria after eight hours (vancomycin dosage 25 
μg mL−1), while H-MSNs permitted bacterial regrowth 
due to an incomplete bacterial destruction. (Table 1)
In another approach to the topic, Li et al studied the 
effect on the morphology and size of silica nanosystems 
(rounded vs rod-like nanoparticles) on the delivery of 
chlorhexidine to several bacterial lines (Streptococcus 
sobrinus, Streptococcus mutans and C. albicans).35 From 
their studies, it is demonstrated that nonmodified MSNs 
were able to adhere better onto bacterial walls as 
a consequence of the interaction between the negatively 
charged silica and peptidoglycans therein. Regarding par-
ticle size these authors found that even with the same 
functionalization, larger particles (over 100 nm) were 
unable to diffuse into the cytoplasm, causing not only 
damage at the bacterial walls, but also not a complete 
antibiotic effect. Regarding chemical functionalization of 
MSNs, two independent studies by Nairi et al36 and 
Deaconu et al37 set the basis for the optimal surface and 
pore modification for the delivery of two different anti-
biotics. In the first, although without a direct evaluation on 
bacteria, Nairi et al studied the differences in loading and 
release of ampicillin from three different silica composi-
tions: SBA-15, amino-modified SBA-15 and MCM-41,36 
finding that the amino modification was the best as it 
achieved a more sustained release profiles. In the second 
contribution the authors studied the effect of chemical 
modification onto different MCM-41-like MSNs on the 
delivery of doxycycline. To do so, the authors prepared 
several sets of nanoparticles including the following che-
mical modifications: phenyl, thiol, sulfonate, Mg+2 doping, 
calcined MCM-41, extracted MCM-41, and commercially 
available MCM-41.37 From the data obtained, the authors 
discovered that for this particular cationic antibiotic, the 
slowest release curves were obtained with either phenyl or 
thiol functionalization and Mg-doping. This behavior 
could be explained by considering the chemical structure 
of the employed drug that enables favorable interactions 
between phenyl groups at the silica with the fused rings on 
the drug and the chelation of Mg cations by hydroxyl 
groups (up to five) present on that particular molecule. 
Unfortunately, although the antibiotic effect of the drug 
loaded into silica did not reach the efficacy levels of free 
drug in a petri dish, it is interesting to know how to modify 
the silica to obtain improved release profiles. In a more 
recent contribution, these same authors also studied the 
effect of several metal-containing MCM-41 nanosystems 
on the loading and release of lomefloxacin 
hydrochloride.38 Herein, as expected, the presence of 
cations (Mg2+, Fe2+, Ce3+, and Zn2+) onto the mesopore 
walls increased the interaction with the antibiotic, slowing 
down the release kinetics. Among all the metals tested, the 
most sustained releases were obtained with Mg2+, that 
together with Zn2+ were the only two systems in which 
silica remained significantly unaltered. (Table 1)
The chemical modification of silica nanoparticles is 
also an interesting possibility to tune drug release pro-
cesses. Along this line Gounani et al, evaluated the release 
profile of polymyxin B from MSNs between 50 and 100 
nm. For their study the authors employed untreated, amino 
modified and carboxylate-modified MSNs.39 From their 
extensive experiments against three human cell lines, it 
could be established that all nanosystems had high bio-
compatibility (up to 80% cell survival with 1500 μg/mL 
nanoparticles) on human HepG2, HEK-293 and HFF-1 
cell lines; being the negatively charged MSNs, the parti-
cles that affected the viability less. Regarding the antibac-
terial effect, all nanoparticles behaved similarly, finding 
values for MIC and minimum biocidal concentrations 
(MBCs) between 1–2 and 2–4 μg/mL, respectively for all 
bacteria tested. Apart from chemical modifications, which 
are aimed at modifying the interactions between cargoes 
and carriers, another interesting possibility is to modify the 
dissolution rates of the carrier itself to enhance drug 
release. This strategy was successfully employed by He 
et al, who prepared mesoporous organosilica nanoparticles 
(MONs) bridged with tetrasulfide bonds with chlorhexi-
dine as the template40 in order to prepare a nanosystem 
able to dissolve in metabolically active microenviron-
ments. As a result, their chlorhexidine-loaded MONs had 
a superior release of the antibiotic under the presence of 
glutathione (GSH) that achieved complete drug release 
within four days. This system was proven to destroy tested 
bacteria and prevent biofilm formation while maintaining 
good cell viabilities (HUVEC and L929) above the typical 
values obtained for free chlorhexidine.
In another interesting set of contributions, 
Subramaniam et al and Joyce et al evaluated the behavior 
between MSNs with different particle sizes41 and surface 
functionalization42 to be tested on S. aureus intracellular 
infections. In these contributions the authors employed 
Hiroshima mesoporous materials (HMM) with sizes 
in the range of 40–100 nm and rifampicin as antibiotic 
cargo. Unfortunately, despite the outstanding biocompat-
ibility of the nanosystem, the antibiotic effect was very 
limited as it had very little internalization within 
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macrophages. Hence, to improve the efficacy the authors 
studied the role of surface chemistry of these HMM MSNs 
by varying the template extraction process. Indeed, the 
MSNs with higher silanol concentration at the surface 
proved to have higher internalization (twofold) into 
Caco-2 adenocarcinoma cells. Although this implementa-
tion is an advance toward more precise nanosystems, it 
does not seem to be enough to develop an effective anti- 
infective nanosystem for intracellular infections according 
to the data shown.43
Silica-containing Composites on 
Antibiotic Delivery
The high chemical stability of silica together with the 
protection offered by its mesoporous structures has per-
mitted us to develop hybrid materials in which several 
features could be combined. For instance, Álvarez et al 
reported a composite device in which antibiotic-loaded 
silica nanoparticles were embedded within collagen 
hydrogels.44 As a result, the system was able to prevent 
bacterial infections thanks to the sustained delivery of 
antibiotic (gentamicin or rifampicin) while the outer col-
lagen layer aided in the healing of chronic wounds. To 
build this system, antibiotic-loaded SiO2 NPs prepared 
in situ from TEOS and ammonia in the presence of anti-
biotics and were coated with a collagen layer afterward. 
As a result, the system had a fivefold increased biocompat-
ibility on fibroblast cell cultures than the raw antibiotic- 
loaded particles while maintaining the antibacterial effect.
Employing a similar strategy the use of antibiotic- 
loaded, nanostructures with silica nanoparticles as compo-
nents for hybrid bone cement composites have been 
reported. Shen et al pioneered the development of bone 
cements with antibiotic properties.45 In their first contribu-
tion the authors prepared poly(methyl methacrylate)-based 
bone cements reinforced with gentamicin-loaded SBA-15 
mesoporous silica. As a result, the complete system 
showed a long-lasting drug delivery without affecting the 
mechanical properties of the cement. The in vitro evalua-
tion of this system on mouse fibroblast cultures showed an 
outstanding biocompatibility, opening the way to the 
in vivo application of such antibiotic-loaded silica- 
polymer composites. In addition to the former example, 
Yan et al also studied the role of chlorhexidine-loaded 
MSNs as components of a glass ionomer composite 
cement.46 In their research the authors found that the 
resulting material was able to destroy S. mutans’ biofilms 
without affecting the mechanical properties of the rein-
forced silica-alumina cement. It is also interesting to 
remark that loadings of about 1% chlorhexidine (approx. 
1 mg antibiotic per cm2 in the cement) obtained a highly 
sustained release able to prevent biofilm formation for up 
to 30 days, increasing the shelf-live of the traditional glass 
ionomer cement. Similar results were obtained on the 
research conducted by Letchmanan et al who also 
employed antibiotic-loaded MSNs into as reinforcement 
in acrylic dental cements.47 In their investigations the 
authors assessed an antibacterial effect of their reinforced 
cements of about four weeks employing a material with 
a 2.72% gentamicin loading. Another interesting formula-
tion suitable for dental applications was reported by Fan 
et al, who employed chlorhexidine-loaded Ca-Si mesopor-
ous nanoparticles to avoid infection in implants while 
enabling bone remineralization.48 Their system showed 
antibiotic effect against planktonic Enterococcus faecalis 
without significant effect on the proliferation of murine 
preosteoblasts even at low concentrations. Moreover, 
when applied on dentin slices, the use of this nanodevice 
promoted an effective mineralization due to the creation of 
hydroxyapatite nanocrystals at the dentin, enabling intra-
dental treatment of infected bone.
Apart from biomaterials aimed at dental applications, 
other biomaterials reinforced with antibiotic-loaded MSNs 
have also been successfully prepared. For instance, aiming 
at bone repairing, Zhou et al employed vancomycin-loaded 
MSNs embedded into a gelatin scaffold to repair infected 
bone defects in rabbits.49 As a result, the prepared compo-
site prevented infection and permitted us to recover 
mineral density and bone volume much faster than the 
raw gelatin scaffold or the hybrid material without the 
antibiotic. For interested readers, a very recent review by 
our group covers this topic in detail.7 Another successful 
combination was reported by Chen et al, who modified 
polycaprolactone fibers with gentamycin-loaded dendritic 
MSNs by electrospinning.50 As a result, the MSN- 
containing nanosystem proved to have a longer and more 
sustained release than the gentamycin-loaded polycapro-
lactone, providing an antibiotic effect able to prevent bac-
teria colonization according to the sensitivity test shown.
Another interesting family of candidates for drug deliv-
ery are lipid-coated nanosystems. Those, apart from pre-
venting undesired drug leakages, also provide an 
outstanding biocompatibility.51 Following this strategy, 
several examples of drug delivery systems could be 
found in the literature. For example, Mudakavi et al 
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designed lipid-coated mesoporous silica nanoparticles as 
an oral delivery system for the targeting and treatment of 
intravacuolar Salmonella infections.52 To do so, the 
authors employed MSNs with sizes between 50 and 100 
nm and a lipid coat of approximately 5 nm thickness 
obtained upon sonication of liposomes. To provoke infec-
tion, bacteria were ingested and monitored on M-cells and 
dendritic cells present in the Peyer’s patches in the small 
intestine, where these bacteria employ a clever molecular 
machinery to invade the gut epithelial barrier. Once inside, 
the bacteria replicate inside the host cell in specialized 
vacuoles called Salmonella-containing vacuoles (SCV), 
evading the immune system. When the authors tested the 
efficacy of their drug-loaded, lipid-coated MSNs, they 
found a high pH dependence on ciprofloxacin release, 
which suggest a preferential release in the stomach rather 
than in the gut. However, the outstanding biocompatibility 
showed by that the lipid layer permitted delivery of this 
nanosystem to the gut to treat the infection. Although the 
delivery mechanism to SCVs is not fully clear, the better 
performance of nanoparticulate antibiotic suggests that 
such a coating may also have some targeting abilities. 
A similar design was employed by Tang et al to create 
a nanosystem able to treat intracellular infections caused 
by S. aureus.53 Their system, based on lipid-coated, gen-
tamicin-loaded MSNs also included the ubiquicidin 
(UBI29−41) bacteria-targeting peptide to ensure an ade-
quate drug delivery. In addition, the coating lipid layer 
was also engineered to be dismantled in the presence of 
metabolically active bacteria. As a result, the system was 
able to enter murine fibroblasts and preosteoblasts, two 
possible reservoirs of bacteria in mammals and reduce 
tissue infection and inflammation according to the values 
of IL-6 and TNF-α reported in the immunohistochemical 
assay.
In addition to lipid layers, some authors have also 
developed alternative coating strategies with outstanding 
biocompatibilities. Such is the case of the nanosystem 
reported by Chen et al who coated ampicillin-loaded 
MSNs with a biomineral calcium phosphate (CaP) layer 
to prevent E. coli and S. aureus infections in mice.54 To 
prepare the nanocarrier the authors employed folic acid 
(FA), which, apart from providing targeting capabilities, 
also favored the biomineralization process. The resulting 
ampicillin-loaded MSN@FA@CaP@FA composite 
proved to have more antibacterial effect than the free 
antibiotic against both bacteria, although E. was much 
more sensitive than S. aureus. The authors also tested 
their system in mice, finding that it was able to inhibit 
cutaneous infections when the nanosystem was applied 
in a topic band formulation. This case obtained a 100% 
survival of the mice with a dose of 1 mg/kg, although 
unfortunately, no data were given about biodistribution 
upon systemic injection or about oral administration.
Delivery of Antibiotic Proteins
In addition to typical antibiotics, there have been reports of 
the use of silica particles with suitable mesopores for the 
delivery of proteins with antibiotic properties. As reviewed 
in a previous contribution by us,21 most examples are 
reported with lysozyme, which is able to hydrolyze gram- 
positive bacterial walls by cleaving the β-1,4 bonds 
between N-acetylmuramic acid and N-acetyl- 
D-glucosamine.
Herein, several approaches for the delivery of lyso-
zyme-containing systems can be found in the literature. 
For instance, in the first example by Li and Wang a direct 
electrostatic interaction was employed to bind the protein 
to negatively charged surfaces of MCM-41 MSNs.55 This 
approach, with exposed proteins, permitted the authors to 
build a stable corona capable of killing both gram-positive 
and negative bacteria due to the release of a protein which 
was able to exert a hydrolytic enzymatic activity onto 
glucosides. Despite the antibacterial effect demonstrated, 
the absence of an efficient enzyme protection prevented 
the system from achieving sustained effects.
Based on this particular combination of silica and 
lysozyme, more recent models improved the antibiotic 
performance by including protective features and 
increased loading capacity of carriers. For example, 
Wang’s and Song’s groups attempted to augment the anti-
bacterial effect by enlarged dendritic mesoporous 
particles56 and a structured silica with rough surface called 
nanopollens,57 respectively. From their studies, it could be 
assessed that the rougher the surface, the better the protein 
loading. Moreover, both silica carriers were able to pre-
serve the enzymatic activity within acceptable levels, thus 
maintaining the antibacterial effect. In a direct comparison 
between both approaches, it could be appreciated that the 
engineered nanopollens provided a more sustained release 
that increased the long-term antibiotic effect, although 
only on planktonic bacteria. In another contribution, Xu 
et al tested silica-carried lysozyme against a formed 
biofilm.58 For this work the authors employed enlarged 
pore, hollow MSNs with a loading capacity of about 
350 mg/g. At this point, it is interesting to remark that 
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the use of the chosen silica carrier produced a highly 
sustained release able to boost the antibacterial effect 
above the maximal activity of free lysozyme (reached at 
400 μg/mL), demonstrating once again that drug delivery 
usually improves the pharmacological effect of free drugs.
Regarding other proteins with antibiotic effect, not 
many examples could be found in the literature. Along 
this line, in an very recent example by us, we demon-
strated the antibacterial effects of the concanavalin 
A (ConA) protein in combination with levofloxacin, 
a typical antibiotic.59 In this example, to combine both 
antibiotic species we employed carboxylate-modified 
MSNs, which were loaded with levofloxacin and functio-
nalized with ConA upon drug loading. The effect of this 
dual-action nanosystem permitted us to achieve a complete 
destruction of the E. coli biofilm even at minimal concen-
trations (10 μg MSNs per mL), improving any of the 
precedent models and showing that combination therapy 
usually improves treatments with single-drug delivery 
systems.17,18
In addition, in a contribution by Durack et al bactofen-
cin A also demonstrated an interesting antibiotic effect 
when loaded into mesoporous matrices.59 In this work 
the authors evaluated the performance of such protein 
when loaded into SBA-15 porous solids against 
S. aureus. Unfortunately, in this case the absence of 
gated pores permitted a fast diffusion of protein that led 
to an almost complete release within five hours, which 
prevented a long-lasting effect as the OD of bacterial 
culture was recovered quickly. Nevertheless, this proof of 
concept also demonstrated that a sustained protein release 
was enough to improve the overall antibacterial effect. 
Besides the previous reported examples, there are also 
other interesting proteins that may be suitable for the 
development of antibiotic nanotherapeutics in the near 
future. Such is the case of lactoferrin, as already developed 
by several research groups and employed for other pur-
poses as postulated by us in a previous contribution.21
Delivery of Antibacterial Peptides
Despite the potential of certain peptide sequences as anti-
bacterial drugs, the fact is that peptides have been very 
poorly exploited as cargoes for silica nanocarriers.21 
Among the examples reported, it could be highlighted by 
the contribution by Braun et al who adsorbed the LL37 
(LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTE-
S) cationic antibacterial peptide onto several surface- 
modified silica nanoparticles (nonporous, calcined 
mesoporous and amino-capped mesoporous).60 
Unfortunately, although loading of the LL-37 peptide 
onto nanoparticles’ surfaces improved the pharmacological 
profile of the free peptide, it still showed significant hemo-
lysis, which prevented its use in typical applications 
in vivo. Nevertheless, the system could be improved by 
the use of other nanocarriers, such as those described 
above, able to fully cloak the peptide’s cationic charge.
As introduced above, the treatment of infected cells, 
especially blood cells, is one of the biggest challenges to 
face in future medicine that could be overcome by using 
nanotechnological approaches. In the example by Tenland 
et al a delivery system was employed to treat infected 
macrophages.61 Herein the known NZX 
(GFGCNGPWSEDDIQCHNHCKSIKGYKGGYCARGG-
FVCKCY) peptide could be successfully threaded within 
the silica mesopores to create a nanosystem able to prevent 
hemolytic damage. As a consequence, the nanocarrier was 
able to internalize into macrophages and once there pro-
duce a sustained release able to exert a long-term antitu-
berculosis effect without comprising the survival of treated 
macrophages and create antituberculosis reservoirs at the 
formed intracellular vacuoles.
Delivery of Other Compounds with 
Antibiotic Properties: Plant Extracts
In addition to the typical drugs, peptides and proteins, also 
of interest is the response of bacteria against certain anti-
biotic compounds present on vegetal extracts. Along this 
line, Balaure et al studied the effect of three essential oils: 
eucalyptus (EUC), orange (ORA), and cinnamon (CIN), 
against clinically relevant species (S. aureus, E. coli and 
Candida albicans) and against the L929 mouse fibroblast 
cell line to ensure biocompatibility.62 The loading of the 
corresponding essential oil into MSNs were carried out 
with the aid of a grinding mortar employing chloroform as 
a volatile additive capable of favoring the loading process 
thanks to a reduction of the oil viscosity and a facile 
evaporation. The resulting oil-loaded MSNs showed 
a significant antibacterial bias depending on the bacteria 
to treat and the oil employed. The best inhibitory effects 
were obtained for C. albicans when the MSNs loaded with 
eucalyptus oil were employed, while for S. aureus orange 
oil performed the best. In the case of E. coli, although 
cinnamon oil provoked certain inhibition that was far away 
from the activity showed by other oil-loaded MSNs. In any 
case, all combinations showed interesting effects on the 
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reduction of biofilm formation, which were significant in 
particle concentrations near 1 µg/mL.
Beyond the previous pioneering contribution, during the 
last year several articles have reported the loading of plant 
extracts with interesting antibacterial properties. Such is the 
example reported by de Azevedo et al, who reported 
a nanosystem loaded with red propolis with proven anti-
bacterial effect onto S. aureus63 or the nanosystem reported 
by Zhou et al who employed tea tree oil as pore-loaded 
antimicrobial agent against E. coli.64,65 Nevertheless, in this 
last example, the authors employed a very convenient poly-
(ethyleneimine) (PEI) coating to prevent undesired oil leak-
age. However, as commented below, the use of cationic 
species on cells have a well demonstrated membrane-lytic 
effect; which could affect the overall antibacterial effect of 
the system throughout a nonstudied combined effect of the 
added plant extract oil and PEI which may diffuse together 
along the bacterial culture.
Behavior of Polyionic MSNs Against 
Bacteria and Biofilms
Antibiotic Effect of Polycation-modified 
Silica Nanoparticles
All kind of cells base their membranes on phospholipid 
bilayers. This fact make these structures highly sensitive to 
polycations and cationic surfactants, which are able to 
produce membrane-lytic processes able to provoke cell 
death (Figure 2).
As expected, this strategy is mostly suitable for the 
disinfection of surfaces and materials, but inadequate for 
living organisms because cationic compounds produce 
high hemolysis rates leading to thrombus that may com-
promise overall survival. Therefore, to overcome this 
limitation several nanotechnological approaches have 
been tested in order to limit the undesired action of catio-
nic species in vivo. In the first example on the topic, 
Trewyn et al reported imidazolium-based ionic liquids as 
antibiotic compounds.66 Unfortunately, although these 
compounds were successfully loaded within the meso-
pores and the system was able to produce a bacterial 
growth inhibition, the noncontrolled release and the 
highly toxic nondegradable cargo prevented their evalua-
tion in eukaryotic cells; although their report set the basis 
for the delivery of antibacterial polycations. Nevertheless, 
the application of polycation-containing MSNs is of inter-
est to prevent the biological colonization of materials and 
surfaces. For instance, an interesting example on the topic 
is the contribution by Wang et al, who prepared hybrid 
composites by layer by layer assemblies of negatively 
charged montmorillonite and ammonium-modified silica 
nanoparticles.67 As a result, their system was able to fully 
destroy gram-positive and gram-negative bacteria due to 
the quaternary ammonium-modified MSNs. In addition to 
the former, Michailidis et al reported a parallel strategy to 
coat MCM-48 MSNs with C-18 and C-14 alkyl substi-
tuted quaternary ammonium salts, although in their 
Figure 2 Strategies to convert silica-containing materials into antibiotic nanodevices by modifying their structure with polyionic species. (A) Loading and release of biocidal 
(cationic) species within mesopores. (B) Surface functionalization with polycations to induce bacterial destruction throughout membrane-lytic processes. (C) Prevention of 
adhesion and/or biofilm formation by modifying the surface with zwitterion-containing structures.
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example a broad range biocide (Parmetol S15) was loaded 
into the mesopores. As a result, the authors were able to 
obtain a surface able to resist the bacterial (and other 
organisms) colonization of these materials in sea water 
for more than five months, proving the potential antibac-
terial effect of combining antibiotic delivery with mem-
brane-lytic features (Table 2). A similar effect was also 
reported by Bai et al, who found a good antibiotic effect 
against E. coli, S. aureus and P. gingivalis employing 
hollow MSNs decorated with C-18 alkyl substituted qua-
ternary ammonium salts and loaded with metronidazole.68
Although the use of permanent cations such as tetra-
alkylammonium halides exhibits unbeatable antibacterial 
effects, they are usually poorly recommended for prevent-
ing infections in the presence of eukaryotic cells and living 
organisms due to the high membrane and hemolysis rates 
showed by these permanent cations. In order to reduce 
such effects, it is highly convenient to employ pH- 
dependent amino-enriched moieties such as lysine- 
enriched polypeptides. Along this line, Velikova et al 
reported the use of ε-poly-L-lysine capping as an antibac-
terial sensitizer to enhance the antibiotic effect of histidine 






















Silica system modified with poly-ions.
MSNs Ionic liquids Membrane 
lysis





















































SBA-15 MSNs APTES- 
CEST-Na
Antifouling None None E. coli Saos-2 None 73
MCM-41 
MSNs





MSNs TES-NMe2-SO3 Antifouling None None E. coli None None 75
Abbreviations: APTES, 3-aminopropyl triethoxysilane; CEST-Na, carboxyethyl silanetriol sodium salt; DAMO, N-(2-aminoethyl)-3- aminopropyltrimethoxysilane; D-C18- 
TMSACl, dimethyloctadecyl [3-(trimethoxysilyl) propyl] ammonium chloride; D-C14-TMSACl, dimethyltetradecyl (3-(trimethoxysilyl)propyl) ammonium chloride; G3-PPI, 
third generation polyethyleneimine dendrimer; HKAI, histidine kinase autophosphorylation inhibitor; HMSNs: hollow MSNs; TES-NMe2-SO3, triethoxysilyl-amidopropyl 
-(dimethyl)-ammonio)propane-1-sulfonate. Eukaryotic cell lines: CaCo-2, human colon carcinoma; Saos-2, human osteoblasts;; RAW 264.7, murine macrophages. 
Prokaryotic cell lines: E. coli, Escherichia coli; M. tuberculosis, Mycobacterium tuberculosis; P. gingivalis, Porphyromonas gingivalis; S. aureus, Staphylococcus aureus.
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kinase autophosphorylation inhibitors.69 IIn this model the 
authors employed carboxylate-modified MCM-41 MSNs 
into which were loaded several inhibitors. Herein the 
polylysine acted as a coating polymer and sensitizer 
against bacteria. According to the authors’ claims, their 
system was able to prevent both gram-positive and nega-
tive bacteria while it permitted the treatment on mamma-
lian cells as suggested by viability and immunotoxicity 
assays carried out on zebrafish.
The use of amine-modified MSNs as antibacterial agents 
has also been successfully reported by our group in several 
approaches. For instance, Pedraza et al demonstrated that 
adequately modified silica nanoparticles in combination 
with a pore-loaded conventional antibiotic was able to 
exert an outstanding antibacterial effect onto gram-positive 
and negative bacteria.70 Herein 2-aminoethyl-aminopropyl 
silane was emplyed to generate polycation coating in 
a broad range of pH due to the combination of primary 
and secondary amines onto the structure. In vitro results 
against E. coli and S. aureus showed that such combination 
of polycations and antibiotic was able to target bacteria and 
destroy preformed biofilms. In a subsequent contribution by 
us, González et al also evaluated the performance of poly-
amine-containing dendrimers as components for preparing 
nano-antibiotics able to combine drug delivery plus bacteria 
targeting and sensitization.71 This second approach obtained 
a double improvement of the original DAMO-modified 
MSNs; as on the one hand retention of levofloxacin was 
improved, while on the other hand, the increase on the 
number of ammonium cations enhanced the interaction of 
nanoparticles and bacteria.
However, despite the promising features of polycationic 
mesoporous nanoparticles as bacterial-targeted nanodevices 
for drug delivery, they would require extensive clinical tests 
to minimize the risks associated to the administration of 
polycations. For this reason, the use of polyions with 
a perfect charge balance has also been the subject of 
study. Nevertheless, as reviewed below, poly-zwitterions 
show different, although very interesting features.
Antibiofilm Effect of Poly-ion Modified 
Silica Nanoparticles
Apart from the antibiotic effect of polycationic species, 
zwitterionic poly-ions also exert an interesting antibacter-
ial feature: the inhibition of adhesion onto surfaces and 
thus the prevention of biofilm formation.72 In comparison 
with other nanosystems, porous nanosilica has become 
a fantastic platform for the development of zwitterion- 
containing nanosystems because of its high chemical com-
patibility and robustness (Figure 2). One of the first exam-
ples on the topic described the effect of modified SBA-15 
nanoparticles with carboxylate, amino or a combination of 
both. As expected, the carboxylate-modified silica did not 
provide an effective antibacterial adhesion while the 
amino-terminated silica led to the expected antimicrobial 
effect based on the membrane-lytic effect. However, when 
the zwitterion-modified silica was employed, it obtained 
an adequately biocompatible system capable of preventing 
bacterial adhesion and biofilm development.73 More 
recently, this strategy was implemented onto MCM-41 
MSNs, which due to the smaller pores have better drug 
release profiles for small molecules.74 In this model two 
implementations were made: the pores were loaded and 
the acid groups changed by more acidic moieties able to 
widen the pH range of zwitterion existence. As a result, 
the system was able to treat macrophages’ infection thanks 
to an increased uptake and a similar biocompatibility to 
polyethylene modified nanoparticles.
More recently other research groups have evolved the 
zwitterion functionalization strategy by including perma-
nent ions and molecules bearing zwitterionic structures 
that upon grafting ensure a perfect distribution of charges 
along the whole structure. In one very interesting contri-
bution Knowles et al employed a silane-modified sulfobe-
taine (triethoxysilyl-amidopropyl-(dimethyl)-ammonio) 
propane-1-sulfonate) to turn raw silica particles into zwit-
terion-modified nanoparticles.75 Their approach main-
tained a successful anti-adhesive feature when tested at 
different pH and against several types of substrates: bac-
teria, proteins, and spores. However, despite these out-
standing results, the authors did not maintain 
a permanent antifouling property due to a pH-driven silica 
degradation that detached the outermost zwitterion func-
tionalization. Nevertheless, instead of being a significant 
limitation this dissolution process enables the clearance of 
silica, improving its biocompatibility.
Indeed, the superior antifouling properties of zwitter-
ion-coated silica particles have permitted us to implement 
such technology onto drug delivery and nanomedicine. For 
instance, Ji et al reported the use of a copolymer of poly-
dopamine (PDA) and a betaine-modified polymer (poly 
(3-(3-methacrylamidopropyl-(dimethyl)-ammonio)pro-
pane-1-sulfonate)) to produce a silica-based nanosystem 
able to be stable up to 72 h into the most common 
media: PBS, BSA, and even FBS.76 In another example, 
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Sanchez-Salcedo et al reported the use of 2-methacryloy-
loxyethyl phosphorylcholine as a zwitterion-incorporating 
agent, which could be grafted onto amines by a Michael 
reaction.77
Antibacterial Effects of Metal-doped 
MSNs
Antibacterial Effects of Silver-silica 
Nanocomposites
In addition to poly-ionic antibacterial nanodevices, another 
blooming field of research is the use of silica nanoparticles 
to deliver cations and metallic nanoparticles, specially of 
silver, able to promote bacterial death throughout an apop-
tosis-like mechanism.78–80 Nevertheless, although known 
for ages, this antibiotic mechanism is not fully understood 
and it could be triggered either with Ag colloids and Ag+ 
cations alike.81 For this reason, it is possible to find nano-
systems based on Ag nanoparticles (AgNPs) and Ag+ 
cations with similar performance, although of course the 
overall dosage of silver when AgNPs are employed is 
significantly higher. Regarding the effect of silver onto 
bacteria there could be highlighted the following aspects: 
(1) gram-negative bacteria are more susceptible due to 
a narrower bacterial wall that facilitates Ag+ 
permeation.82 (2) A fully functional biofilm protects bac-
teria from both silver ions and nanoparticles by reducing 
their mobility throughout its architecture, specially in the 
case of larger nanoparticles. And (3), highly charged par-
ticles would experience diffusion issues due to strong 
electrostatic interactions between particles and biofilms.83 
For this reason, best antibacterial effects are typically 
obtained with nanosystems on which cationic silver is 
released (Figure 3).
On one of the first contributions to the topic, Zink and 
coworkers pioneered the use of Ag-Silica nanohybrids for 
the treatment of infections.84 On this work the authors 
prepared Ag@MSNs which was further loaded with 
a PEI polymer, proving an antibacterial effect in two cell 
lines E. coli and B. anthracis. However, the reported anti-
biotic effect is not fully clear; as it could be caused either 
by a pH-driven detachment of the coating PEI, by a release 
of Ag+ throughout the mesopores or by combination of 
both. Nevertheless, their results set the basis for future 
experiments in both silver delivery with nanometric silica 
devices and combination therapies. (Table 3).
Despite the advance reported by Zink and coworkers, 
sequent works were focused on designing nanodevices 
onto which the antibacterial AgNPs would be exposed 
instead of encapsulated into silica in order to accelerate 
the antibacterial effect. Along this line Tian et al reported 
the use of a ethylenediamine moiety onto silica’s surface 
to coordinate Ag+ ions onto which grow AgNPs.85 Their 
nanosystem was able to inhibit both a gram-negative 
(E. coli) and gram-positive (S. aureus) bacteria in liquid 
cultures; although this device was much more effective 
when tested against the gram-negative E. coli bacteria 
(OD600 dropped to zero at 80μg/mL MSN@Ag) than 
against S. aureus (OD600=0 at 320μg/mL MSN@Ag). 
Regarding the effect onto HUVEC eukaryotic cells, the 
authors found a 10-fold increased biocompatibility of car-
ried silver when compared to free silver cations (added as 
AgNO3).
The previous results pushed other research groups to 
investigate the potential of MSN@Ag hybrids as nanoan-
tibiotics; although with additional mechanisms to control 
AgNPs release in order to have more sustained effects. 
Along this line Wan et al employed sulfonate-modified 
MSNs onto which coordinate Ag+ to further prepare 
monodisperse AgNPs by in-situ reduction.86 With this 
approach the authors prepared a model in which the result-
ing AgNPs had a relative small size and a fantastic dis-
persion throughout the silica, allowing to reach complete 
destruction of E. coli colonies at a concentration near 
50μg/mL and S. aureus at about 150μg/mL. Following 
a parallel strategy, Song et al employed sulfonate- 
modified SBA-15 MSNs to prepare their MSN@AgNPs; 
although in this case with an additional coating of 
Figure 3 Different known antibiotic effects triggered by metals colloids and 
cations. These effects are of particular importance with silver, although known for 
Cu, Zn, and Fe among other metals.
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polydopamine which embedded the MSN@AgNPs 
hybrids.87 The resulting system proved to be effective 
against E. coli, S. aureus and A. fumigatus colonies at 
a concentration of 4mg of the nanocomposite per petri 
dish; although much faster on the case of gram-negative 
E. coli.
Our group has been also interested on the use of Ag- 
Silica composites in the fight of infections. On a very 
recent contribution Montalvo-Quirós et al studied the dif-
ferent performance of both approaches reviewed so far: 
a core-shell structure in which a big AgNP is coated by 
a silica layer and model that grows AgNPs within the 
mesopores.88 Both structures were prepared successfully 
and tested against M. tuberculosis. It was found that the 
approach onto AgNPs were grown at the mesopores had 
a higher antibiotic effect that could be assumed to be 
consequence of an increased dissolution rate of AgNPs 
together with a more intimate contact between particles 
and mycobacteria.
The previous examples, focused on measuring the anti-
bacterial activity, show the great potential of these Ag- 
SiO2 systems. However, it is also interesting to know how 
these nanoantibiotics perform in clinical applications. 
Along this line Ambrogi et al reported the use of 
Ag@MSNs embedded in alginate to prepare composite 
films for wound treatments.89 Here in, the topic 















































Ag decomplexation E. coli 
S. aureus
None None 86


























































E. faecalis MC3T3-E1 None 94
Abbreviations: AgNPs, silver nanoparticles; PEI, polyethyleneimine; eukaryotic cell lines: HuDe, human dermis fibroblast; HUVEC, human umbilical vein endothelial cells; 
NCTC2544, human skin keratinocytes; Prokaryotic cell lines: A. fumigatus, Aspergillus fumigatus; B. anthracis, Bacillus anthracis; B. subtilis, Bacillus subtilis; C. albicans, Candida 
albicans; E. coli, Escherichia coli; M. tuberculosis, Mycobacterium tuberculosis; S. aureus, Staphylococcus aureus.
International Journal of Nanomedicine 2021:16                                                                                   https://doi.org/10.2147/IJN.S273064                                                                                                                                                                                                                       
DovePress                                                                                                                       
4423
Dovepress                                                                                                                                             Castillo and Vallet-Regí



































































administration of silver-silica composites permits to have 
more laxity on particles’ size and morphology, which will 
reduce the final cost. The system proposed by these 
authors showed effective antibiotic effects on typical 
bacterial lines and onto the C. albicans yeast. In addition, 
due to the alginate and silica layers the silver toxicity was 
diminished to acceptable levels as showed on cellular 
assays onto human keratinocyte and fibroblast cell lines.
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Pore loading Pore diffusion E. coli 
S. aureus
MCF-7 None 104



















































Abbreviations: EMPO, ethane bridged periodic mesoporous organosilica; HMSNs, hollow MSNs; PEI, polyethyleneimine; MMSNs, core-shell magnetic MSNs; LP-MSNs, 
large-pore MSNs. Eukaryotic cell lines, HEK293T, human embryonic kidney; HeLa, human cervix adenocarcinoma; NIH3T3, murine embryonic fibroblasts; MCF-7, human 
breast ductal carcinoma. Prokaryotic cell lines, B. subtilis, Bacillus subtilis; E. coli, Escherichia coli; K. pneumoniae, Klebsiella pneumoniae; M. tuberculosis, Mycobacterium tuberculosis; 
P. aeruginosa, Pseudomonas aeruginosa; P. gingivalis, Porphyromonas gingivalis; S. aureus, Staphylococcus aureus; S. epidermis, Staphylococcus epidermis; S. mutans, Staphylococcus 
mutans.
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Antibacterial Effects of Metal-doped 
Mesoporous Silica Nanocomposites
Apart from silver, many other metals are also known to 
show antibacterial properties.90–92 Although this effect is 
significantly lower than that provided by Ag, their lower 
costs and rapid availability also makes them interesting 
candidates for the development of silica-based nanoanti-
biotics. Along this line, Hachemaoui et al studied the 
antibacterial effect achieved of MCM-41 MSNs doped 
with several cations.93 Their results showed that between 
the metals tested there were no significant differences 
regarding antibacterial effects, although a clear bias 
could be appreciated toward non-calcined materials, 
which in all cases improved the performance of calcined 
ones according to the Kirby–Bauer tests reported. From 
these data, it could be assumed that the main antibiotic 
mechanism is metal diffusion, which is known to be less 
efficient into calcined materials. One other interesting 
contribution, Leng et al compared the antibiotic effect of 
silver- and zinc-doped mesoporous calcium silicates for 
dental fillings.94 Their results show that both cations and 
their combinations exert a low biocidal effect against 
E. faecalis and murine preosteoblasts, but a significant 
reduction of the number of colonies formed and thus on 
the biofilm formation, a highly valuable feature to prevent 
dental implant failure. Moreover, the enhanced activity of 
the Zn-Ag combination is also interesting because apart 
from reducing costs it also improves the overall perfor-
mance, bringing out the potential of single-device antibio-
tic combinations.
One of the last metals to arrive for antibacterial 
treatment is iron, either in a colloidal form95,96 or as 
doping element. The antibacterial possibilities of iron 
are huge as they can perform such effects by either 
thermal destruction of bacteria,97 production of toxic 
reactive oxygen species (ROS) throughout Fenton-like 
reactions17,92 or upon a membrane depolarization only 
in the case of iron oxide particles (IONs).98 Despite the 
number of IONs@MSN nanosystems reported with 
promising applications on anticancer therapy, we did 
not find any silica-containing nanodevice applied 
against bacterial infection. Perhaps in the near future 
the outstanding performance of IONs as ferroptosis 
inductors and thermal sensitizer in combination with 
mesoporous silica would produce a new family of anti- 
infectives.
Combined Antibiotic Therapies
Combination therapy has become a powerful tool for 
nanomedicine, as it allows us to exert several effects 
with a single device, as reviewed by us focused on cancer 
therapy;17,18 and similarly, bacterial infections could be 
treated with more than one biocidal. Among all the possi-
bilities we will focus on the main strategies developed so 
far in order to shed some light onto a very complex field of 
research (Table 4).
Antibiotic Codelivery
The first and easiest way to combine antibiotic effects is 
simultaneous loading and delivery of drugs. However, to 
implement this strategy, a gating component would be 
needed at the pore in order to prevent undesired leakages 
and to enable bacterial-triggered drug release. However, 
reported examples seem to be on a previous development 
stage as they do not include this feature. In the example by 
Mebert et al99 the loading was achieved by using 
a multilayered construction of silica nanoparticles with 
a step-by-step loading of gentamicin and rifamycin. In 
contrast, Aguilar-Colomer et al10 and Gounani et al100 
employed the convenient porous structure of MSNs (either 
SBA-15 or MCM-41) to co-load two antibiotic species. In 
general, the results show good bacterial remission, 
although due to the diffusion-driven release, these exam-
ples may not be suitable for intracellular infections and 
parenteral administration. Another interesting example on 
the topic was reported by Kuthati et al who employed Ag 
−indole-3-acetic acid hydrazides (Ag-IAA) complexes to 
kill bacteria.101 Herein, the Ag+ cations and the indole- 
acetic acid prodrug could be simultaneously delivered due 
to the pH-sensitive hydrazide bonds that connected Ag- 
IAA to mesopores. This nanosystem, tested against several 
bacterial lines showed good antibiotic effect, although 
even in the absence of a specific reductor for the IAA 
a maximal effect could not be obtained.102
Regarding other possible combinations, we want to 
highlight the work by Yu et al who reported the co- 
delivery of the antimicrobial peptide melittin with 
ofloxacin.103 For this device example the authors employed 
a well-developed technology onto which large pore MSNs 
containing the peptide were coated with a cucurbituril- 
modified PEI onto which assemble adamantane-modified 
magnetic MSNs to close the pores. The system, which 
was disassembled under alternating magnetic fields, proved 
to have a good antibacterial effect against P. aeruginosa and 
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good biocompatibility against HEK293 and NIT3T3 cell 
lines. Another interesting approach to co-deliver substances 
is the use of Janus nanoparticles, in this case with different 
adsorption domains. Along this line, Cheng et al reported 
the use of core-shell magnetic MSNs (MMSNs) grafted to 
ethane-bridged mesoporous periodic organosilica (EMPO) 
with different loading properties. Herein the authors profited 
from two different loading rates between the two employed 
silica materials: gentamicin was preferentially loaded 
between the silica while the curcumin within the 
organosilica.104 The resulting system proved to have 
a good biocidal performance as was able to destroy bacteria 
and cancerous cells alike, demonstrating the potential of 
drug combinations.
Silver-containing Silica Nanoparticles for 
Antibiotic Delivery
Silver-containing silica nanoparticles reviewed above have 
also been successfully employed for combination treat-
ments. In one of the first examples reported, Wang et al 
reported the use of core-shell AgNPs@MSNs loaded with 
levofloxacin to treat peritoneal infection on mice.105 
Herein the authors studied the Ag dissolution kinetics 
proving that the internal core was able to dissolve slowly, 
releasing silver ions able to cause bacterial damage. In this 
article, two bacterial lines were successfully destroyed 
with this combination and when tested in vivo this system 
was capable of promoting survival of mice with acute 
peritonitis.
Another possible strategy to combine AgNPs and 
mesoporous silica was reported by Chang et al, who 
reported the use of Janus-Silver-MSN nanobullets in 
which the silica mesopores were filled with the forming 
template CTAB.106 In this case, the authors prepared 
a very simplified model into which the AgNP was exposed 
and permitted a facile Ag+ release and the porous silica 
remained unextracted and was able to release membrane- 
lytic cetyltrimethylammonium cations (CTA+). Moreover, 
the authors also claimed that the silica surface was able to 
stabilize Ag+ ions and boost the antibacterial activity. This 
system as is, is a very interesting a proof of concept; 
although in its current configuration, lacking from protec-
tive coatings able to prevent CTA+ release and immune- 
stealthening, has very few possibilities to be applied 
in vivo.
Regarding silver-doped silica particles, two interesting 
approaches on the recent literature were found. For 
instance, Tasia et al reported the use of Ag-doped, large 
pore MSNs suitable to load and deliver the DNase 
I enzyme107 with great effect on E. coli and S. mutans 
biofilms due to the combination of Ag+ sensitization and 
enzymatic degradation of the intracellular DNA; although 
the lack of a protective layer may lead to a very limited 
shelf-life of the enzyme. This limitation could be over-
come by using the system reported by Song et al, who 
designed polydopamine-coated Ag-doped SBA-15 MSNs 
to deliver curcumin to both bacteria and cancerous 
cells.108 In this case, despite the potential of their nano-
system the chosen drug did not produce a significant antic-
ancer effect. However, an opposite effect was observed 
onto prokaryotic cells, which permitted complete destruc-
tion of E. coli colonies at 2 mg per petri dish and 
a significant colony formation (up to 36 h) against 
S. aureus.
Conclusion
This review has focused on the use of silica nanoparticles 
and related silica-based hybrids as promising nanotechno-
logical approaches for the control and treatment of infec-
tious processes. Herein, apart from visiting the most recent 
advances in drug delivery published so far, we have high-
lighted the most promising applications of mesoporous 
silica on preventive nanomedicine.
Regarding drug delivery, it is widely accepted that 
the unique porous structure of mesoporous silica is 
a highly desired feature for the development of new- 
generation pharmacological formulations; ranging from 
controlled delivery to the development of unique multi-
drug delivery systems. During the last decade those 
aspects have been widely studied on the development 
of anticancer nanosystems, although unfortunately, the 
desired effective leap toward clinical research has not 
yet been taken. For this reason, current research on 
MSNs seems to have shifted from anticancer nanomedi-
cine to anti-infective processes that avoid parenteral drug 
delivery. For instance, it has been possible to design 
effective formulations based on porous silica as compo-
nents for cements and dental filling materials or even 
topical formulations able to keep bacterial infection 
under control with common antibiotics. We believe that 
antibiotic drug delivery will bloom during the following 
years; as MSNs are one of the very few platforms that 
permit implementation of (1) multidrug delivery, (2) 
dosage of antibiotic peptides and (3) the exploitation of 
extracts and oils as mild antibiotics. Perhaps this 
https://doi.org/10.2147/IJN.S273064                                                                                                                                                                                                                                    
DovePress                                                                                                                                         
International Journal of Nanomedicine 2021:16 4426
Castillo and Vallet-Regí                                                                                                                                             Dovepress



































































evolution may avoid the intravenous injection but may 
have a future in implants and drug patch technologies.
Apart from the promising advances on drug delivery, 
MSNs also have demonstrated an outstanding robustness 
against chemical modifications. This permits us to create 
polyionic compounds with antibacterial and antibiofilm 
properties. Again, it is clear that clinical assays are still to 
be made, but it is also important to remark that very few of 
those nanosystems are really in an anti-infection race. 
Indeed, even less of these materials would allow us to imple-
ment the current state-of-the-art in nanopharmaceutical 
research on future antibacterial applications; silica being 
one of the best candidates for such purpose. To conclude, it 
is also important to remark that silica allows, like no other 
material, the development of hybrid nanosystem able to 
combine therapeutic features. For instance, the combination 
with colloidal silver has permitted us to develop interesting 
candidates for synergic therapies.
In summary, we believe that the topics reviewed herein 
highlight the potential of MSNs and related materials for the 
development of effective nanoantibiotics. Furthermore, in the 
light of the reported examples, we truly believe that silica is 
still to pioneer a revolution in the development of new genera-
tion antibacterial nanotherapeutics in disciplines like dentistry, 
wound care, and regenerative tissue engineering.
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